CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.17B, above the global median of $1.15B
- FinancialsAltman Z-Score 6.3: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
4.47%Above 5Y avg (4.16%)
Annual Rate
CNY 0.60Paid semi-annual
Payout Ratio
71.4%Moderate
Payback Period
26.5 yr
Last Ex-Dividend
Jun 4, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.87BCNY1.17B · vs all stocks (USD)
Trailing P/E
17.40xRevenue (TTM)
2.10BCNY312.06M · vs all stocks (USD)
Profit Margin
21.51%Beta
0.1740xvs all stocks
52-Week Change
-14.35%vs all stocks
Forward Annual Dividend Yield
4.47%vs all stocks
Market Capitalization
7.87BCNY1.17B · vs all stocks (USD)
Enterprise Value
6.53BCNY967.95M · vs all stocks (USD)
Trailing P/E
17.40xForward P/E
14.11xPrice to Sales (TTM)
3.74xPrice to Book (MRQ)
2.37xEnterprise to Revenue
3.10xEnterprise to EBITDA
10.62xGross Margin
82.26%Profit Margin
21.51%Operating Margin
28.14%Return on Assets (TTM)
7.71%Return on Equity (TTM)
14.02%Revenue (TTM)
2.10BCNY312.06M · vs all stocks (USD)
Revenue per Share (TTM)
3.58CNYUpdated Aug 19, 2026Quarterly Revenue Growth
12.50%Gross Profit (TTM)
1.61BCNY238.22M · vs all stocks (USD)
EBITDA (TTM)
655.51MCNY97.21M · vs all stocks (USD)
Net Income (TTM)
452.67MCNY67.13M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
18.60%Operating Cash Flow (TTM)
668.60MCNY99.15M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
458.37MCNY67.98M · vs all stocks (USD)
Forward Annual Dividend Rate
0.6000CNYUpdated Aug 19, 2026Forward Annual Dividend Yield
4.47%vs all stocks
Trailing Annual Dividend Rate
0.5000CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
3.72%vs all stocks
5-Year Average Dividend Yield
4.16%vs all stocks
Payout Ratio
71.43%Revenue
2.05BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
490.41MCNYFY2025 · Dec 31, 2025Gross Profit
1.56BCNYFY2025 · Dec 31, 2025Operating Income
568.15MCNY84.26M · vs all stocks (USD)
Pre-tax Income
536.93MCNYFY2025 · Dec 31, 2025Income Tax Expense
103.79MCNYFY2025 · Dec 31, 2025Net Income
433.13MCNYFY2025 · Dec 31, 2025EBIT
556.78MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
689.27MCNYFY2025 · Dec 31, 2025Research & Development
160.04MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
576.77MCNYFY2025 · Dec 31, 2025Other Operating Expenses
33.22MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
18.62MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
19.86MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7400CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7400CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
585.32MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
585.32MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
433.13MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
653.56MCNYFY2025 · Dec 31, 2025Free Cash Flow
566.67MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
719.84MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
433.13MCNYFY2025 · Dec 31, 2025Other Non-cash Items
13.91MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
216.70MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-10.19MCNYFY2025 · Dec 31, 2025Capital Expenditures
-86.88MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.52BCNYFY2025 · Dec 31, 2025Sale of Investments
1.48BCNYFY2025 · Dec 31, 2025Other Investing Activity
-300.74MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-429.21MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
355.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-428.68MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-341.05MCNYFY2025 · Dec 31, 2025Other Financing Charges
40.16MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-374.56MCNYFY2025 · Dec 31, 2025Shares Outstanding
587.57MSharesUpdated Aug 19, 2026Float Shares
133.62MSharesUpdated Aug 19, 2026% Held by Insiders
78.03%vs all stocks
% Held by Institutions
0.92%vs all stocks
Total Cash (MRQ)
1.74BCNY257.93M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.96CNYUpdated Aug 19, 2026Total Debt (MRQ)
439.78MCNY65.22M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1323xCurrent Ratio (MRQ)
3.97xBook Value per Share (MRQ)
5.66CNYUpdated Aug 19, 2026Total Assets
4.26BCNY631.49M · vs all stocks (USD)
Total Current Assets
2.36BCNYFY2025 · Dec 31, 2025Total Liabilities
1.07BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.89BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
282.77MCNYFY2025 · Dec 31, 2025Total Current Liabilities
784.39MCNYFY2025 · Dec 31, 2025Cash
959.72MCNYFY2025 · Dec 31, 2025Cash Equivalents
31.27MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
990.99MCNYFY2025 · Dec 31, 2025Other Short-term Investments
730.31MCNYFY2025 · Dec 31, 2025Accounts Receivable
81.70MCNYFY2025 · Dec 31, 2025Inventory
203.26MCNYFY2025 · Dec 31, 2025Accounts Payable
185.76MCNYFY2025 · Dec 31, 2025Short-term Debt
306.29MCNYFY2025 · Dec 31, 2025Other Current Liabilities
12.07MCNYFY2025 · Dec 31, 2025Long-term Debt
207.50MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
5.05MCNYFY2025 · Dec 31, 2025Common Stock (Book)
587.57MCNYFY2025 · Dec 31, 2025Retained Earnings
1.57BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.19BCNY473.23M · vs all stocks (USD)
52-Week Low
11.91CNYUpdated Aug 19, 202652-Week High
15.75CNYUpdated Aug 19, 202652-Week Change
-14.35%vs all stocks
Beta
0.1740xvs all stocks
50-Day MA
13.03CNYUpdated Aug 19, 2026200-Day MA
14.04CNYUpdated Aug 19, 2026Avg 10-Day Volume
2.14MSharesUpdated Aug 19, 2026Avg 30-Day Volume
2.29MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.7700CNYUpdated Aug 19, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Cash Backing With OCF Coverage And Cash Near Total Debt
Cash on hand covers most or all of its total debt, and cash flow matches reported earnings.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 6.3: safe zoneNotable
Altman Z-Score: 6.30
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.17B, above the global median of $1.15BNotable
Market cap (USD): 1,167,628,073.292Global Median: 1,146,734,693.424
Levered free cash flow is $67.98M, above the global median of $16.24MNotable
Levered free cash flow (USD): 67,976,657.766Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Glass House Brands Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Northeast Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Sanofi Consumer Healthcare Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Avanos Medical Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Collegium Pharmaceutical Inc.
Tier 1ProductionApproval-Gated PipelineRule
Tandem Diabetes Care Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
0009K0
Tier 1ProductionApproval-Gated PipelineRuleRisk
BioGaia AB
Tier 1ProductionApproval-Gated PipelineRuleFlow
Eton Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Wuxi Honghui New Materials Co., Ltd.
3 interpretationsCash Backing With OCF Coverage And Cash Near Total DebtClose Below 40W SMA With ProfitabilityMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Oriental Watch Holdings Limited
3 interpretationsCash Backing With OCF Coverage And Cash Near Total DebtClose Below 40W SMA With ProfitabilityMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Doximity Inc.
3 interpretationsCash Backing With OCF Coverage And Cash Near Total DebtClose Below 40W SMA With ProfitabilityMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities